ATE395352T1 - 17.alpha.-hydroxy-14.beta.-steroide mit hormonaler wirkung - Google Patents
17.alpha.-hydroxy-14.beta.-steroide mit hormonaler wirkungInfo
- Publication number
- ATE395352T1 ATE395352T1 AT02777036T AT02777036T ATE395352T1 AT E395352 T1 ATE395352 T1 AT E395352T1 AT 02777036 T AT02777036 T AT 02777036T AT 02777036 T AT02777036 T AT 02777036T AT E395352 T1 ATE395352 T1 AT E395352T1
- Authority
- AT
- Austria
- Prior art keywords
- steroids
- beta
- alpha
- hydroxy
- hormonal effects
- Prior art date
Links
- 230000003054 hormonal effect Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
- C07J1/0051—Estrane derivatives
- C07J1/0062—Estrane derivatives substituted in position 17 alfa not substituted in position 17 beta
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/16—Masculine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/26—Androgens
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Endocrinology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Diabetes (AREA)
- Reproductive Health (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP01203455 | 2001-09-12 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE395352T1 true ATE395352T1 (de) | 2008-05-15 |
Family
ID=8180920
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT02777036T ATE395352T1 (de) | 2001-09-12 | 2002-09-06 | 17.alpha.-hydroxy-14.beta.-steroide mit hormonaler wirkung |
Country Status (28)
| Country | Link |
|---|---|
| US (1) | US7169769B2 (enExample) |
| EP (1) | EP1427748B1 (enExample) |
| JP (1) | JP4471653B2 (enExample) |
| KR (1) | KR100940054B1 (enExample) |
| CN (1) | CN1257913C (enExample) |
| AR (1) | AR036462A1 (enExample) |
| AT (1) | ATE395352T1 (enExample) |
| AU (1) | AU2002339536B2 (enExample) |
| BR (1) | BR0212409A (enExample) |
| CA (1) | CA2505575C (enExample) |
| CY (1) | CY1108152T1 (enExample) |
| DE (1) | DE60226623D1 (enExample) |
| DK (1) | DK1427748T3 (enExample) |
| EC (1) | ECSP045012A (enExample) |
| ES (1) | ES2305306T3 (enExample) |
| HR (1) | HRP20040193A2 (enExample) |
| HU (1) | HUP0402139A3 (enExample) |
| IL (2) | IL160451A0 (enExample) |
| IS (1) | IS2555B (enExample) |
| MX (1) | MXPA04002418A (enExample) |
| NO (1) | NO326624B1 (enExample) |
| NZ (1) | NZ531487A (enExample) |
| PL (1) | PL207493B1 (enExample) |
| PT (1) | PT1427748E (enExample) |
| RU (1) | RU2294332C2 (enExample) |
| TW (1) | TWI221154B (enExample) |
| WO (1) | WO2003022864A1 (enExample) |
| ZA (1) | ZA200401992B (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI221154B (en) | 2001-09-12 | 2004-09-21 | Akzo Nobel Nv | 17alpha-hydroxy-14beta-steroids with hormonal effect |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3338925A (en) * | 1965-10-25 | 1967-08-29 | Syntex Corp | 17-substituted 14beta-estr-4-enes |
| WO2000053619A1 (en) * | 1999-03-08 | 2000-09-14 | Akzo Nobel N.V. | 14.beta., 17-alpha-hydroxymethylandrostane derivatives as androgens |
| AU4299301A (en) * | 2000-02-29 | 2001-09-12 | National University Of Singapore, The | A method for modulating steroidogenic activity |
| US6391868B2 (en) * | 2000-05-10 | 2002-05-21 | Lpt Research, Inc. | Use of 5-alpha-androst-1-en-3,17-dione to increase the level of the anabolic/androgenic hormone 17-beta-hydroxy-5-alpha-androst-1-en-3-one in humans |
| TWI221154B (en) | 2001-09-12 | 2004-09-21 | Akzo Nobel Nv | 17alpha-hydroxy-14beta-steroids with hormonal effect |
-
2002
- 2002-07-19 TW TW091116164A patent/TWI221154B/zh not_active IP Right Cessation
- 2002-09-06 HR HR20040193A patent/HRP20040193A2/hr not_active Application Discontinuation
- 2002-09-06 JP JP2003526937A patent/JP4471653B2/ja not_active Expired - Fee Related
- 2002-09-06 CN CNB02817853XA patent/CN1257913C/zh not_active Expired - Lifetime
- 2002-09-06 NZ NZ531487A patent/NZ531487A/en not_active IP Right Cessation
- 2002-09-06 AT AT02777036T patent/ATE395352T1/de active
- 2002-09-06 EP EP02777036A patent/EP1427748B1/en not_active Expired - Lifetime
- 2002-09-06 IL IL16045102A patent/IL160451A0/xx unknown
- 2002-09-06 US US10/489,456 patent/US7169769B2/en not_active Expired - Lifetime
- 2002-09-06 PT PT02777036T patent/PT1427748E/pt unknown
- 2002-09-06 HU HU0402139A patent/HUP0402139A3/hu unknown
- 2002-09-06 DK DK02777036T patent/DK1427748T3/da active
- 2002-09-06 ES ES02777036T patent/ES2305306T3/es not_active Expired - Lifetime
- 2002-09-06 MX MXPA04002418A patent/MXPA04002418A/es active IP Right Grant
- 2002-09-06 PL PL368727A patent/PL207493B1/pl not_active IP Right Cessation
- 2002-09-06 RU RU2004110934/04A patent/RU2294332C2/ru not_active IP Right Cessation
- 2002-09-06 BR BR0212409-2A patent/BR0212409A/pt not_active IP Right Cessation
- 2002-09-06 AU AU2002339536A patent/AU2002339536B2/en not_active Expired
- 2002-09-06 KR KR1020047003609A patent/KR100940054B1/ko not_active Expired - Fee Related
- 2002-09-06 CA CA2505575A patent/CA2505575C/en not_active Expired - Lifetime
- 2002-09-06 DE DE60226623T patent/DE60226623D1/de not_active Expired - Lifetime
- 2002-09-06 WO PCT/EP2002/010041 patent/WO2003022864A1/en not_active Ceased
- 2002-09-10 AR ARP020103415A patent/AR036462A1/es unknown
-
2004
- 2004-02-18 IL IL160451A patent/IL160451A/en not_active IP Right Cessation
- 2004-02-26 IS IS7165A patent/IS2555B/is unknown
- 2004-03-10 EC EC2004005012A patent/ECSP045012A/es unknown
- 2004-03-10 NO NO20041010A patent/NO326624B1/no not_active IP Right Cessation
- 2004-03-11 ZA ZA200401992A patent/ZA200401992B/en unknown
-
2008
- 2008-06-19 CY CY20081100653T patent/CY1108152T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60202270D1 (de) | 4,5-dihydro-1h-pyrazolderivate mit cb1-antagonistischer wirkung | |
| NO2012018I1 (no) | Canakinumab eller direkte ekvivalenter derav | |
| DE60209302D1 (de) | Elektronisch leitfähige Polythiophenteilchen enthaltende Zusammensetzung | |
| IS6915A (is) | Lyfjablanda | |
| BR0210619A (pt) | composição | |
| IS7081A (is) | Lyfjablanda | |
| EP1426370A4 (en) | PROPANOLAMINE DERIVATIVE WITH 1,4-BENZODIOXANE CORE | |
| DE60101126D1 (de) | Tintenstrahlaufzeichnungselement | |
| FI20011518A0 (fi) | Liikeanalysaattori | |
| DE60025958D1 (de) | 14,15-beta-methylen substituierte androgene | |
| DE60044181D1 (de) | Gleitvorrichtung | |
| DE50110880D1 (de) | Gleitelementvorrichtung | |
| DE60102606D1 (de) | Tintenstrahlaufzeichnungselement | |
| DE60101705D1 (de) | Tintenstrahlaufzeichnungselement | |
| ITTO20020744A1 (it) | Composizione. | |
| ATE395352T1 (de) | 17.alpha.-hydroxy-14.beta.-steroide mit hormonaler wirkung | |
| DE60232170D1 (de) | Thieno-(1,3)-oxazin-4-one mit lipase inhibierender wirkung | |
| ITTO20020745A0 (it) | Composizione | |
| DE60111997D1 (de) | Tintenstrahlaufzeichnungselement | |
| ES1049286Y (es) | Expositor. | |
| SE0101369D0 (sv) | Free 4 ever | |
| ITTO20020746A1 (it) | Composizione. | |
| SE0103455D0 (sv) | The W/F/T-Sens 1 | |
| ES1041780Y (es) | Vitrina perfeccionada. | |
| ES1042344Y (es) | Tornillo. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1427748 Country of ref document: EP |